IGS Project management of 11 components/moulds for one drug delivery device

IGS GeboJagema, a global healthcare mould maker based in the Netherlands, has announced two strategic acquisitions: ACH Solution, an Austrian specialist in silicone rubber injection moulds, including liquid silicone rubber (LSR) and high temperature vulcanizing silicone rubber (HTV), and the medical device operations of FRP, a UK-based rapid prototyping specialist. Together, the acquisitions significantly expand IGS GeboJagema’s ability to serve medical device clients.

Enabling sustainable injection moulding. The efforts to combat climate change will havea huge impact on the world economy over thenext decade and beyond. Greenhouse gasemissions must be reduced dramatically. TheEU is aiming at a reduction of 55% by 2030,compared to 1990 levels.* Similar goals arebeing set both by countries and companies inthe rest of the world.To achieve reductions of this magnitude, all sectors andindustries must investigate ways to do more with less. Thisapplies to all companies involved in injection mouldingas well. Traditionally, the critical factors for moulds havebeen accuracy, cycle time, reliability and maintenancefriendliness.But as the world takes steps towards a carbonneutral economy, we expect that energy usage will becomeincreasingly important.